Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Ro 3306

Base Information
  • Chemical Name:Ro 3306
  • CAS No.:872573-93-8
  • Molecular Formula:C18H13N3OS2
  • Molecular Weight:351.44500
  • Hs Code.:
  • Mol file:872573-93-8.mol
Ro 3306

Synonyms:(5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one;

Suppliers and Price of Ro 3306
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Ro 3306
  • 10mg
  • $ 480.00
  • Usbiological
  • RO-3306
  • 1mg
  • $ 290.00
  • Tocris
  • Ro3306 ≥98%(HPLC)
  • 50
  • $ 952.00
  • Tocris
  • Ro3306 ≥98%(HPLC)
  • 10
  • $ 227.00
  • TCI Chemical
  • RO-3306
  • 50MG
  • $ 378.00
  • TCI Chemical
  • RO-3306
  • 10MG
  • $ 127.00
  • Sigma-Aldrich
  • RO-3306 ≥98% (HPLC)
  • 5mg
  • $ 118.00
  • Sigma-Aldrich
  • RO-3306 ≥98% (HPLC)
  • 25mg
  • $ 467.00
  • DC Chemicals
  • RO-3306 >98%
  • 100 mg
  • $ 650.00
  • Crysdot
  • Ro-3306 98+%
  • 100mg
  • $ 591.00
Total 24 raw suppliers
Chemical Property of Ro 3306
Chemical Property:
  • Boiling Point:569.1±60.0 °C(Predicted) 
  • PKA:3.99±0.10(Predicted) 
  • PSA:107.89000 
  • Density:1.41 
  • LogP:3.88290 
  • Storage Temp.:2-8°C 
  • Solubility.:DMSO: soluble5mg/mL, clear 
Purity/Quality:

99%, *data from raw suppliers

Ro 3306 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Description RO-3306 (872573-93-8) is a selective inhibitor of CDK1 (IC50?= 35 nM versus CDK2 IC50?= 340nM).1,2?It induces G2/M phase cell cycle arrest and apoptosis. Inhibition of CDK1 with RO-3306 has been shown to have synergistic effects with PARP inhibitors in treating various breast cancers.3,4?It has also been demonstrated to overcome apoptotic resistance in BRAFV600E?human colorectal cancer cells.5
  • Uses RO-3306 is an ATP-competitive and selective CDK1 inhibitor used against a diverse panel of human kinases. Used in the treatment of malignant tumors in conjunction with PARP inhibitors. RO-3306 has been used:To study the significance of CA4-mediated cytotoxicity in mitotic arrest In cell cycle synchronization to conduct a study on proteomics As a CDK1 inhibitor, to prevent early mitotic entry
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 872573-93-8